Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 15, 2022 at 07:01 am EDT
Share
Panacea Life Sciences Holdings, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.469472 million compared to USD 0.313496 million a year ago. Net loss was USD 1.96 million compared to net income of USD 0.027214 million a year ago. Basic loss per share from continuing operations was USD 0.13.
For the six months, sales was USD 0.935946 million compared to USD 0.825634 million a year ago. Net loss was USD 4.74 million compared to net income of USD 0.397864 million a year ago. Basic loss per share from continuing operations was USD 0.32 compared to basic earnings per share from continuing operations of USD 0.02 a year ago.
Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company. It specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Companyâs subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The Company also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. It also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.
PANACEA LIFE SCIENCES HOLDINGS, INC. 
